货号:A238234
同义名:
NSC 57654; (–)-3',5,7-Trihydroxy-4'-methoxyflavanone
Hesperetin是一种从柑橘皮中提取的黄酮,能抑制 PDE4 和 UGT。它还具有抗氧化和抗炎作用。在细胞实验中,Hesperetin 以剂量依赖的方式抑制了 3CLpro 的裂解活性,IC50 值为 8.3 μM。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | PDE ↓ ↑ | PDE1 ↓ ↑ | PDE10A ↓ ↑ | PDE2 ↓ ↑ | PDE3 ↓ ↑ | PDE4 ↓ ↑ | PDE5 ↓ ↑ | PDE6 ↓ ↑ | 其他靶点 | 纯度 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Doxofylline | ✔ | 99+% | |||||||||||||||||
| Deltarasin |
+++
PDEδ , Kd: 38 nM |
95% | |||||||||||||||||
| 7-(2,3-Dihydroxypropyl)theophylline | ✔ | 98% | |||||||||||||||||
| Aminophylline |
+
PDE, IC50: 0.12 mM |
98+% | |||||||||||||||||
| Anagrelide HCl | ✔ | 99%+ | |||||||||||||||||
| Irsogladine | ✔ | AChR,mAChR | 99% | ||||||||||||||||
| PF-8380 |
+++
Autotaxin, IC50: 2.8 nM |
99%+ | |||||||||||||||||
| Dipyridamole | ✔ | 98% | |||||||||||||||||
| Balipodect |
++++
PDE10A, IC50: 0.3 nM |
99%+ | |||||||||||||||||
| Luteolin |
+
PDE1, Ki: 15.0 μM |
++
PDE2, Ki: 6.4 μM |
+
PDE3, Ki: 13.9 μM |
+
PDE4, Ki: 11.1 μM |
+
PDE5, Ki: 9.5 μM |
98% | |||||||||||||
| Milrinone |
++
PDE2, IC50: 5.2 μM |
++
PDE3, IC50: 2.1 μM |
ATPase | 99% | |||||||||||||||
| Pimobendan |
++
PDE3, IC50: 0.32 μM |
98% | |||||||||||||||||
| Cilostazol |
++
PDE3, IC50: 0.2 μM |
98% | |||||||||||||||||
| Fenspiride HCl |
+
PDE3, pIC50: 3.44 |
+
PDE4, pIC50: 4.16 |
99% (HPLC) | ||||||||||||||||
| (S)-(+)-Rolipram |
++
PDE4, IC50: 0.75 μM |
99% (HPLC) | |||||||||||||||||
| Apremilast |
+++
PDE4, IC50: 74 nM |
98% | |||||||||||||||||
| GSK256066 |
++++
PDE4B, IC50: 3.2 pM |
98+% | |||||||||||||||||
| Roflumilast |
++++
PDE4A1, IC50: 0.7 nM PDE4A4, IC50: 4.3 nM |
99% | |||||||||||||||||
| Rolipram |
+++
PDE4B, IC50: 130 nM |
99%+ | |||||||||||||||||
| Cilomilast |
+++
LPDE4, IC50: 100 nM HPDE4, IC50: 120 nM |
99% | |||||||||||||||||
| Avanafil |
++++
PDE5, IC50: 1 nM |
98% | |||||||||||||||||
| Vardenafil HCl Trihydrate |
++++
PDE5, IC50: 0.7 nM |
98% | |||||||||||||||||
| Tadalafil |
++++
PDE5, IC50: 1.8 nM |
98% | |||||||||||||||||
| Icariin |
++
PDE5, IC50: 0.432 μM |
98% | |||||||||||||||||
| Sildenafil | ✔ |
+++
PDE6, IC50: 33 nM |
98% | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Hesperetin is an effective antioxidant and anti-inflammatory agent. Hesperetin conferred neuroprotection by regulating the TLR4/NF-κB (Toll-like receptor-4) signaling pathway against the detrimental effects of LPS(lipopolysaccharide) [3]. Hesperetin (HET) and naringenin (NGR) are flavanones found in citrus (oranges and grapefruit) and Aurantii Fructus Immaturus. HET and NGR displayed broad-spectrum inhibition against human UGTs. HET exhibited strong inhibitory effects on UGT1A1, 1A3 and 1A9 (both IC50 and Ki values lower than 10 µM) [4]. Hesperetin interacts with different types of proteins involving hydrogen bonds, pi-pi effects, pi-cation bonding and pi-sigma interactions with varying binding energies. Hesperetin exhibits drug-like properties which projects its potential as a therapeutic option for CHIKV infection[5]. Preadministration of Hesperetin (40 mg/kg b.w., oral) significantly attenuated the Cd-induced (cadmium) oxidative stress and mitochondrial dysfunction, restored the antioxidant and membrane-bound enzyme activities and decreased apoptosis in the brain of rats[6]. Hesperetin (200 mg/kg) attenuates Con A-induced hepatocyte apoptosis and hepatic Nos2 (iNOS) expression in mice. Hesperetin blocked bile acid-induced apoptosis and cytokine-induced inflammation in rat hepatocytes[7]. |
| Concentration | Treated Time | Description | References | |
| HeLa cells | 100 µM | 1 hour | To study the effect of hesperetin on the binding of TGF-β1 to TβRII, results showed that hesperetin reduced the probability of ligand-receptor binding. | Eur J Med Chem. 2012 Dec;58:390-5. |
| Lewis lung carcinoma (LLC) cells | 30 µM | 1 hour | To evaluate the protective effect of hesperetin against acrolein-induced toxicity in LLC cells. Results showed that hesperetin pretreatment significantly increased cell viability and reduced the expression of apoptosis marker proteins (e.g., cleaved caspase-3, cleaved PARP, cytochrome C, and p-p53). | Redox Rep. 2018 Dec;23(1):188-193. |
| HeLa cells | 100 µM | 24 hours | To study the effect of hesperetin on TGF-β1-induced cell migration, results showed that hesperetin inhibited cell migration capacity. | Eur J Med Chem. 2012 Dec;58:390-5. |
| SH-SY5Y AßPPwt cells | 0.01–10 µM | 24 hours | To evaluate the antioxidant capacity and changes in ATP levels of hesperetin nanocrystals in an Alzheimer’s disease cell model. Results showed that hesperetin nanocrystals significantly increased ATP levels, with more pronounced effects observed in 170 nm nanocrystals. | Drug Deliv Transl Res. 2021 Apr;11(2):659-674. |
| HEK293-CISD2 reporter cells | 10-30 µM | 24 hours | Screening for CISD2 activators via luciferase reporter assay, hesperetin enhances CISD2 expression | J Biomed Sci. 2022 Jul 24;29(1):53. |
| Human aortic valve interstitial cells (VICs) | 3 µM | 24 hours | Hesperetin pretreatment inhibited LPS-induced NF-κB inflammatory cytokine secretion and osteogenic factor expression, reduced ROS production and apoptosis, and abrogated LPS-mediated injury to the mitochondrial membrane potential and the decline in antioxidant levels in VICs. | Antioxidants (Basel). 2022 Oct 24;11(11):2093. |
| SH-SY5Y-MOCK cells | 0.01 to 10 µM | 24 hours | The effects of HstN on SY5Y-MOCK control cells were relatively small. HstP had almost no effect on both cell lines. | Antioxidants (Basel). 2021 Jun 23;10(7):1003. |
| SH-SY5Y-APP695 cells | 0.01 to 10 µM | 24 hours | HstN significantly reduced mitochondrial dysfunction: ATP levels and respiratory chain complex activity significantly increased. Gene expression levels of RCC I, IV, and V were significantly upregulated. HstP had almost no effect on both cell lines. | Antioxidants (Basel). 2021 Jun 23;10(7):1003. |
| AGS cells | 0, 6.25, 12.5, 25, 50 µM | 24 hours | To evaluate the effect of hesperetin on the translocation of CagA and VacA proteins into AGS cells infected with H. pylori. Results showed that hesperetin treatment significantly reduced the translocation of CagA and VacA proteins. | Int J Mol Sci. 2021 Sep 17;22(18):10035. |
| THP-1 macrophages | 0–40 μg/mL | 24 hours | Evaluate the inhibitory effect of Hesperetin on Spike S1-induced inflammatory responses, significantly reducing the release of IL-6, IL-1β, and IL-18 | Moore Inhibits SARS-CoV-2 Spike Protein S1 Subunit-Induced NLRP3 Inflammasome in A549 Lung Cells via Modulation of the Akt/MAPK/AP-1 Pathway. Int J Mol Sci. |
| A549 lung cells | 0–40 μg/mL | 24 hours | Evaluate the inhibitory effect of Hesperetin on Spike S1-induced inflammatory responses, significantly reducing the release of IL-6, IL-1β, and IL-18 | Moore Inhibits SARS-CoV-2 Spike Protein S1 Subunit-Induced NLRP3 Inflammasome in A549 Lung Cells via Modulation of the Akt/MAPK/AP-1 Pathway. Int J Mol Sci. |
| HT-22 cells | 50 µM | 24 hours | To evaluate the effect of hesperetin on LPS-induced cytotoxicity and ROS/LPO. Hesperetin significantly reduced LPS-induced cytotoxicity and ROS/LPO levels. | Nutrients. 2019 Mar 17;11(3):648. |
| BV2 cells | 50 µM | 24 hours | To evaluate the effect of hesperetin on LPS-induced TLR4 and Iba-1 protein expression. Hesperetin significantly reduced LPS-induced TLR4 and Iba-1 protein levels. | Nutrients. 2019 Mar 17;11(3):648. |
| HEK001-shCISD2 cells | 10 µM | 48 hours | In CISD2 knockdown cells, hesperetin loses its beneficial effects on mitochondrial function and antioxidant capacity | J Biomed Sci. 2024 Jan 23;31(1):15. |
| HEK001 human keratinocytes | 10 µM | 48 hours | Enhances mitochondrial function and protects against ROS-induced oxidative stress via increased CISD2 expression | J Biomed Sci. 2024 Jan 23;31(1):15. |
| H226 cells | 75, 150, 300 µM | 48 hours | To evaluate the effect of HST on the viability of H226 cells, results showed that HST inhibited cell viability in a concentration- and time-dependent manner, induced G2/M phase cell cycle arrest and apoptosis. | Int J Mol Med. 2025 May;55(5):77. |
| H1703 cells | 37.5, 75, 150 µM | 48 hours | To evaluate the effect of HST on the viability of H1703 cells, results showed that HST inhibited cell viability in a concentration- and time-dependent manner, induced G2/M phase cell cycle arrest and apoptosis. | Int J Mol Med. 2025 May;55(5):77. |
| HepG2 cells | 20 µM and 40 µM | 4-hours pretreatment followed by 24-hours PA stimulation | To investigate the inhibitory effect of hesperetin on PA-induced cell death and NLRP3 inflammasome activation in HepG2 cells. Results showed that hesperetin significantly increased cell viability, reduced cell death, and inhibited PA-induced IL-1β and IL-18 mRNA expression and NLRP3 and caspase-1 protein expression. | J Agric Food Chem. 2024 Jun 12;72(23):13039-13053. |
| A549/DDP cells | 0.6, 1.25, 2.5, 5, 10 µM | 72 hours | Assessed the toxic effects of hesperetin on A549/DDP cells and its synergistic effect with cisplatin; concentrations ≥2.5 µM significantly enhanced the cytotoxicity of DDP | Int J Mol Med. 2020 Apr;45(4):1213-1224. |
| Human lung adenocarcinoma A549 cells | 0.6, 1.25, 2.5, 5, 10, 20, 40, 80, 160 µM | 72 hours | Evaluated the toxic effects of hesperetin on A549 cells; low concentrations (<5 µM) had no significant effect, while higher concentrations (>20 µM) significantly inhibited cell proliferation | Int J Mol Med. 2020 Apr;45(4):1213-1224. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Naturally aged mouse model | Oral | 100 mg/kg/day | Continued for 3-6 months | Hesperetin extends healthspan, ameliorates age-related metabolic decline, body composition changes, glucose dysregulation, and organ senescence | J Biomed Sci. 2022 Jul 24;29(1):53. |
| Mice | Naturally aged mice | Oral | 100 mg/kg/day | Once daily for 5 months | Enhances CISD2 expression, improves skin aging phenotypes, and reduces ROS levels | J Biomed Sci. 2024 Jan 23;31(1):15. |
| Nude mice | A549/DDP xenograft model | Intragastric administration | 2 mg/kg | Every 2 days for 52 days | Evaluated the inhibitory effect of hesperetin on A549/DDP cell growth in vivo; hesperetin pretreatment significantly inhibited tumor growth | Int J Mol Med. 2020 Apr;45(4):1213-1224. |
| BALB/c nude mice | H226 xenograft model | Intraperitoneal injection | 30, 60, 90 mg/kg | Once every 2 days for 28 days | To evaluate the anti-tumor effect of HST on H226 xenograft tumors, results showed that HST significantly inhibited tumor growth without apparent toxic side effects. | Int J Mol Med. 2025 May;55(5):77. |
| C57BL/6 mice | Direct wire injury (DWI)-induced aortic valve stenosis model | Oral gavage | 50 mg/kg | Once daily for 7 days | Hesperetin supplementation protected mice from wire-injury-induced aortic valve stenosis; in vivo, hesperetin corrected dysfunctional mitochondria by activating the Nrf2-ARE signaling pathway. | Antioxidants (Basel). 2022 Oct 24;11(11):2093. |
| C57BL/6N mice | LPS-induced neuroinflammation model | Oral gavage | 50 mg/kg | Daily for a total of five weeks | To evaluate the effect of hesperetin on LPS-induced neuroinflammation, oxidative stress, and memory impairments. Hesperetin significantly reduced LPS-induced neuroinflammation, oxidative stress, and memory impairments. | Nutrients. 2019 Mar 17;11(3):648. |
| C57BL/6 mice | Acrolein-induced lung injury model | Intraperitoneal injection | 60 mg/kg | Single dose, lasting 12 hours | To investigate the protective effects of hesperetin on acrolein-induced lung damage. Results showed that hesperetin pretreatment significantly improved lung tissue structure, reduced fibrosis and apoptosis marker protein expression, and decreased oxidative stress markers (e.g., Prx-SO3, HNE, and 8-OH-dG). | Redox Rep. 2018 Dec;23(1):188-193. |
| Sprague Dawley rats | High-fat diet and streptozotocin (STZ)-induced type 2 diabetes rat model | Oral gavage | Hesperetin 50 mg/kg/day, Metformin 100 mg/kg/day | Once daily for six weeks | To investigate the effect of hesperetin-enhanced metformin on alleviating cognitive impairment in diabetic rats and its mechanism | Int J Mol Sci. 2025 Feb 23;26(5):1923 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.31mL 0.66mL 0.33mL |
16.54mL 3.31mL 1.65mL |
33.08mL 6.62mL 3.31mL |
|
| CAS号 | 520-33-2 |
| 分子式 | C16H14O6 |
| 分子量 | 302.28 |
| SMILES Code | O=C1C[C@H](OC2=C1C(O)=CC(O)=C2)C3=CC=C(C(O)=C3)OC |
| MDL No. | MFCD00075646 |
| 别名 | NSC 57654; (–)-3',5,7-Trihydroxy-4'-methoxyflavanone; Prestwick_908; YSO2; Hesperin; Hesperitin; (S)-Hesperetin; (–)-Hesperetin |
| 运输 | 蓝冰 |
| InChI Key | AIONOLUJZLIMTK-AWEZNQCLSA-N |
| Pubchem ID | 72281 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(396.98 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1